유방 병변 위치특정 시장 보고서 : 유형, 용도, 최종 사용자 및 지역별(2024-2032년)

The global breast lesion localization methods market size reached US$ 1,214.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,656.8 Million by 2032, exhibiting a growth rate (CAGR) of 8.9% during 2024-2032.

Breast lesion localization methods refer to various procedures employed to detect abnormal changes in the breast tissue, also called a breast lesion, caused due to a disease or injury. Some commonly used methods include wire localization, carbon marking, radio-guided occult lesion localization (ROLL), radioactive seed localization (RSL), magnetic seed localization (Magseed), and intraoperative ultrasound (IOUS). These techniques assist doctors and healthcare professionals in making informed decisions and determining the ideal treatment or surgery for the patient. With advancements in surgical, imaging and biomedical technology, breast lesion localization methods have significantly evolved, which is presently driving their demand in the healthcare sector.

Breast Lesion Localization Methods Market Trends:

A significant increase in breast cancer cases due to changing lifestyles, and unhealthy diets represents the primary factor driving the market growth. Besides this, the growing number of patients requiring lumpectomy and surgical biopsy procedures is augmenting the demand for breast lesion localization methods to ensure accurate removal of the target lesion. Additionally, the governing agencies of various countries are taking favorable initiatives to spread awareness regarding the benefits of early detection of breast cancer. For instance, the Government of Australia launched BreastScreen Australia, a national breast cancer screening program that provides a free mammogram to women aged 50-74 every two years. This, in confluence with the increasing number of government and private reimbursement policies for breast cancer diagnosis, biopsy and other related medical procedures and the launch of innovative breast lesion localization devices by leading players, is catalyzing the market growth. Furthermore, heavy investments in research and development (R&D) activities are offering lucrative opportunities to the market players. Other factors, including the rising number of individuals undergoing cosmetic surgeries like breast enhancement, improving healthcare infrastructure, technological advancements, and increasing consumer healthcare spending, are also creating a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global breast lesion localization methods market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, usage and end user.

Breakup by Type:

Wire Localization

Radioisotope Localization

Magnetic Tracers Localization

Others

Breakup by Usage:

Tumor Identification

Sentinel Lymph Node Identification

Lumpectomy

Mastectomy

Breakup by End User:

Hospitals

Diagnostic Centres

Oncology Clinics

Ambulatory Surgical Centers

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Argon Medical Devices Inc., Becton Dickinson and Company, Cook Group Incorporated, CP Medical Inc. (Theragenics Corporation), Endomagnetics Ltd., Hologic Inc., IsoAid LLC, IZI Medical Products (Landauer Inc), Laurane Medical LLC, Leica Biosystems Nussloch GmbH (Danaher Corporation), Merit Medical Systems Inc. and Sterylab S.r.l.

Key Questions Answered in This Report

• 1. What was the size of the global breast lesion localization methods market in 2023?
• 2. What is the expected growth rate of the global breast lesion localization methods market during 2024-2032?
• 3. What are the key factors driving the global breast lesion localization methods market?
• 4. What has been the impact of COVID-19 on the global breast lesion localization methods market?
• 5. What is the breakup of the global breast lesion localization methods market based on type?
• 6. What is the breakup of the global breast lesion localization methods market based on the usage?
• 7. What is the breakup of the global breast lesion localization methods market based on the end user?
• 8. What are the key regions in the global breast lesion localization methods market?
• 9. Who are the key players/companies in the global breast lesion localization methods market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Breast Lesion Localization Methods Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Wire Localization
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Radioisotope Localization
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Magnetic Tracers Localization
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Usage

• 7.1 Tumor Identification
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Sentinel Lymph Node Identification
  • 7.2.1 Market Trends
  • 7.2.2 Key Segments
    • 7.2.2.1 Lumpectomy
    • 7.2.2.2 Mastectomy
  • 7.2.3 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Diagnostic Centres
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Oncology Clinics
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Ambulatory Surgical Centers
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Argon Medical Devices Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Becton Dickinson and Company
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Cook Group Incorporated
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 CP Medical Inc. (Theragenics Corporation)
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Endomagnetics Ltd.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Hologic Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 IsoAid LLC
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 IZI Medical Products (Landauer Inc)
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Laurane Medical LLC
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Leica Biosystems Nussloch GmbH (Danaher Corporation)
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Merit Medical Systems Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 Sterylab S.r.l
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio